血单胺转运体在神经母细胞瘤中高度表达,并作为mIBG转运体起作用

Letícia Salvador Vieira1, Yuchen Zhang1, Antonio J López Quiñones1

  • 1Department of Pharmaceutics, University of Washington, Seattle, Washington (L.S.V., Y.Z., A.J.L.Q., T.H., J.W.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (D.K.S., B.P.); and Seattle Children's Hospital, Seattle, Washington (J.S., J.R.P.).

概括

血单胺转运体 (PMAT) 是神经母细胞瘤中一种新型的转运体. 它的表达影响患者的生存,并可能改善高风险神经母细胞瘤I-mIBG治疗的反应.